event-trade登录编辑
RTTNews BiotechDoubao · 实盘不做把握 7/10不做原因:标的无直接敞口
北京时间·🕒 发布 20:10:02·⟳ 抓取 20:15:26 +5m24s·⚡ 决策 10-08 20:16:25 +59s·19.2 天前

Avricore Health 子公司 HealthTab 完成与英国 HeartEye 的集成,新增社区药房心血管风险转诊路径

公告是无金额、无订单、无用量数据的系统集成/转诊 PR,缺乏对盈利或现金流的可量化增量;唯一直接标的 AVCR.V 为流动性极差的毫角股,不具备可执行的正期望交易。

📄 原文RTTNews Biotech↗ 原文
Avricore Expands Community Pharmacy Referral Network With HeartEye Integration
Business Business Latest Headlines Top Stories Breaking News Earnings Biotech Investors Stock Alerts IPOs M&A Canadian…
不做 Avricore Health Inc.(AVCR.CA)
无金额、无订单的系统集成 PR,缺乏可量化基本面催化;标的为 CAD 0.06 的极低流动性 TSX Venture 毫角股,成交与止损均不可靠,无正期望,不做
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)

研究档案

结论摘要

HealthTab 与 HeartEye 的集成属于业务拓展性合作,扩大潜在转诊入口,但未披露任何收入或商业条款;直接标的 Avricore 为 CAD 0.06 的极低流动性创业股,消息无财务量级,无可交易 edge,故回避。

🔎 新鲜度:最早出现 2026-10-08 · 扩散 low · price-in 风险 low ↗

关键理由

  • 无金额、无订单、无收入分成的集成公告,无法建立对公司基本面的可量化正向催化
  • AVCR.V 为毫角股、流动性差,价格易被小幅资金操纵,止损与成交均不可靠

主要风险

  • 若后续披露英国大型连锁药房签约或检测量数据,可能构成实质增量,需重新评估
  • 毫角股可能因 PR 出现短线投机脉冲,但无基本面支撑、不可持续

反向证据

  • 做多前查反向 · 来源 web · 日期 2026-10-08 · 影响 weakens
    公告通篇未披露金额、订单、收入分成或检测量,仅有产品展示与政策背景(英格兰药剂师独立处方权),无业绩增量证据
    检索:Avricore Health HealthTab 集成 是否带来收入/订单/财务指引 原文 ↗

先例如何影响了这次决策

对本次决策的影响:缺乏可量化催化与可靠先例,支持回避而非以小仓博弈

方向:无可用对齐先例;毫角股无金额集成类 PR 不构成可统计的有效事件类别

涨幅量级:无高相似先例校准幅度,且事件本身无财务增量,不宜据投机脉冲设定止盈

形态:未做先例统计

工具执行结果 · 成功 1 · 降级 0 · 失败 0 · 取消 0
  1. search_processed_events 成功 stock_tools HTTP · 18 ms
    {"result": "search_processed_events:agent query=`avcr hearteye retinal pharmacy referral | avricore health healthtab hearteye integration | healthtab community pharmacy cardiovascular referral network`;结构化索引覆盖完整 72 小时;旧记录兼容扫描近 0.0/72 小时、0 条本臂决策(完整),返回 0 条候选。未命中只表示这些 agent query 表达式没有召回候选,不能据此证明消息首发或

原文全文

展开原文 · 9,085 字
Avricore Expands Community Pharmacy Referral Network With HeartEye Integration
Business
Business
Latest Headlines
Top Stories
Breaking News
Earnings
Biotech
Investors
Stock Alerts
IPOs
M&A
Canadian
UK
Wallstreet Events
Industry News
Industry News
Technology
Software
Banking
Automotive
Energy
More
Corp. Calendars
Dividends
Stock Splits
Buybacks
Conference Calls
Earnings Calendar
Earnings Calendar
Pos Pre-announcements
Profit Warnings
Positive Surprise
Negative Surprise
Latest Earnings
FDA Calendars
Drug Approvals
Clinical Trial Calendar
Ratings Changes
Upgrades
Downgrades
Cov Initiations
Cov. Reiterated
Economy
Economic News
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard
Cryptocurrency
Crypto
Cryptocurrency
Blockchain
Markets
Markets
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies
Politics
Politics
US
World
White House
Elections
General News
Forex
Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard
Health
Health
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health
Slide Shows
Entertainment
Entertainment
Top Stories
Music news
Pop
Rock
Classic Rock
Rap/Hip-Hop
Country
Alternative
Oldies
All Genre
Content Licensing
Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services
Premium Services
Premium
Intelligent Investor
Biotech Investor
NEW
Login
More
Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us
Biotech Daily Dose
Avricore Expands Community Pharmacy Referral Network With HeartEye Integration
By
RTTNews Staff Writer
✉
Published:
10/8/2026 8:10 AM ET
Follow Us
Join Us
Add
as your preferred news source on Google
Add Now
Avricore Health Inc. (AVCR) announced that its wholly owned subsidiary HealthTab has completed an integration with HeartEye, a UK provider of AI-based retinal cardiovascular risk assessment, creating a new referral pathway into community pharmacies.
The integration allows people identified as having elevated cardiovascular risk through HeartEye's retinal scan at participating opticians to be referred to nearby HealthTab-enabled pharmacies for further assessment and care.
HeartEye's Dr.Noon CVD test uses artificial intelligence to estimate cardiovascular risk from a retinal scan. Patients flagged as being at elevated risk can have their report QR code scanned into HealthTab at a participating pharmacy.
Pharmacists can then perform a point-of-care cholesterol test, with the results feeding into an automated QRISK3 calculation. The retinal assessment, cholesterol results and cardiovascular risk assessment are displayed together through the HealthTab dashboard.
Avricore said the pathway could support identification, assessment and, where appropriate, treatment within community pharmacies, following the introduction of independent prescribing for newly qualified pharmacists in England from September 2026.
The companies will showcase the integrated solution at The Pharmacy Show 2026 in Birmingham on October 11-12, alongside Abbott's pharmacy-based point-of-care testing solution.
HealthTab provides a cloud-based platform connecting point-of-care testing devices, patient results, quality-control data and pharmacist workflows across community pharmacy networks.
Avricore said the integration could help expand access to cardiovascular risk assessment while providing pharmacy partners with a new pathway for patients identified through community-based screening programs.
AVCR.V has traded between CAD 0.045 and CAD 0.10 over the past year.
The stock closed Wednesday's trading at CAD 0.06, down 7.69%.
For comments and feedback contact: editorial@rttnews.com
Business News
Slide Shows
Biotech Stocks Facing FDA Decision In October 2026
Biotech Stocks Facing FDA Decision In September 2026
Biotech Stocks Facing FDA Decision In August 2026
Latest Updates on Middle East War
U.S. Stocks Giving Back Ground Following Recent Strength
October 07, 2026 11:01 ET
Profit Taking May Contribute To Initial Pullback On Wall Street
October 07, 2026 08:57 ET
U.S. Stocks May Move Back To The Upside In Early Trading
September 29, 2026 08:54 ET
U.S. Stocks Under Pressure As Crude Oil Prices, Treasury Yields Surge
September 28, 2026 11:06 ET
U.S. Stocks Close Mostly Higher Amid Sharp Pullback By Crude Oil
September 25, 2026 16:27 ET
View More
October 2026 FDA Decisions: 4 Key Drug Approvals Biotech Investors Should Watch
September 28, 2026 06:25 ET
Every month, the FDA issues decisions on drug approvals — and for biotech investors, these dates are important milestones for the companies and patients involved. In this video, we highlight five key FDA decisions scheduled for October 2026, covering potential approvals and expanded indications across oncology, rare diseases, ophthalmology, and chronic hepatitis B.
View More Videos
RELATED NEWS
Avricore Expands Community Pharmacy Referral Network With HeartEye Integration
HealthTab Partners With Abbott For UK Point-of-Care Testing Expansion
Latest Updates on COVID-19
View More
Editor's Pick
Most Read
Most Emailed
ISIS-inspired Teenager Who Plotted Mass-Shooting At Mall Of America Arrested
October 08, 2026 07:39 ET
British Consulate In East Jerusalem Not Closing, But Renamed As UK Mission
October 08, 2026 07:21 ET
Istanbul Overtakes London Heathrow As World's Most-connected Airport
October 08, 2026 07:00 ET
Tesco Plc Stock Gains On H1 Profit Growth, FY27 Outlook Upgrade, Addl. Buyback
October 08, 2026 05:39 ET
Fed Minutes Reveal Officials Expect Another Rate Hike This Year
October 07, 2026 14:23 ET
RBI Shifts To 'Calibrated Tightening' As Rate-Hiking Cycle Begins
October 07, 2026 12:14 ET
No Dangerous Infectious Disease Detected Among Russia Lab Worker Contacts: WHO
October 07, 2026 08:48 ET
French, Japanese Chemists Win Nobel Prize For Solving Molecular Mystery
October 07, 2026 08:42 ET
'Rising Temperatures Mean Rising Danger In Pregnancy,' UNFCCC Chief Warns
October 07, 2026 08:19 ET
FAA To Accelerate Commercial Space Licensing
October 07, 2026 07:07 ET
NASA's SunRISE Mission To Launch No Earlier Than Mid-2027
October 07, 2026 06:52 ET
Christa Pike 'conscious And Speaking' After Failed Execution, Her Lawyers Say
October 07, 2026 06:49 ET
AkzoNobel To Sell Southeast Asia Decorative Paints Business To Nippon Paint In $1.35 Bln Deal
October 04, 2026 21:49 ET
Google's Fitbit Edge Tracker May Cost Around $180 With 7-Day Battery Life
October 06, 2026 18:17 ET
CD&R And McKesson To Acquire Option Care Health
October 06, 2026 08:23 ET
Applied Digital Secures Access To 1 GW Power Capacity In Finland
October 06, 2026 15:07 ET
Emera, Canadian Utilities To Merge In C$72 Bln Deal
October 06, 2026 07:23 ET
Constellation Acquires SpikeAde For $75 Mln; Shares Down
October 06, 2026 17:22 ET
IRhythm Begins Notifying Patients Following Review Of Cybersecurity Incident
October 04, 2026 03:07 ET
PepsiCo Recalls Gatorade In 37 States Over Undeclared Dyes
October 05, 2026 18:04 ET
Fairfax Financial To Partner With Wittington To Acquire Boots Group
October 07, 2026 09:49 ET
Nexus Advanced Technologies Signs Exclusivity For $500 Mln Defense Tech Reverse Merger
October 06, 2026 08:31 ET
Genmab Reports Positive Phase 1/2 Data For Rina-S In Resistant Ovarian Cancer
October 04, 2026 01:40 ET
Advanced Drainage Systems To Acquire StormTrap For $530 Mln
October 05, 2026 07:08 ET
Bayer To Invest $2.2 Bln In Ohio Pharma Manufacturing Campus
October 03, 2026 10:21 ET
Novo Nordisk Plans Denecimib U.S. Launch In H1 2027 Amid FDA Review Extension
October 03, 2026 09:12 ET
IRhythm Begins Notifying Patients Following Review Of Cybersecurity Incident
October 04, 2026 03:07 ET
FDA Approves Expanded Use Of Lilly's Jaypirca For CLL/SLL
October 03, 2026 10:42 ET
CSL, Alentis Therapeutics Partner On Lixudebart In Deal Worth Up To $1.6 Bln
October 04, 2026 21:10 ET
Bayer To Invest $2.2 Bln In Ohio Pharma Site, To Create 2,100 Jobs
October 03, 2026 11:03 ET
AkzoNobel To Sell Southeast Asia Decorative Paints Business To Nippon Paint In $1.35 Bln Deal
October 04, 2026 21:49 ET
Genmab Reports Positive Phase 1/2 Data For Rina-S In Resistant Ovarian Cancer
October 04, 2026 01:40 ET
Kaneko Seeds Co Ltd Reports Rise In Q1 Bottom Line
October 05, 2026 00:33 ET
FAA Reportedly Finds Boeing 737 Max Software Issue Poses No Safety Risk
October 04, 2026 10:53 ET
Skanska Enters Contract For New High School Project In Renton
October 05, 2026 02:05 ET
Oracle Invests $10 Mln To Support Nashville Symphony's Recovery And Restore Operations
October 04, 2026 20:44 ET
Editors Pick
Tesco Plc Stock Gains On H1 Profit Growth, FY27 Outlook Upgrade, Addl. Buyback
October 08, 2026 05:39 ET
Walmart Recalls Over 4.4 Mln Grill Brushes For Ingestion Risk
October 02, 2026 09:11 ET
Gias Foods Recalls Bettergoods Pasta Sold At Walmart Over Listeria Risk
October 02, 2026 08:47 ET
Accenture Shares Climb On Strong Q4, Positive Outlook, $9.5 Bln Return Plan
October 01, 2026 09:20 ET
Loading...

决策记录链 · 只追加

每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。

这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。